Evidence map›Paper›PMID 38830959›Full record

Trial reportLeukemia2024

CD8

Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig and 26 more

Abstract readClinical Trial, Phase IIIMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. T Cells Dysfunction in Multiple Myeloma.ImmunoTargets and therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Katharina Kriegsmann *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Gigi Nu Hoang Quy Ton *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Mohamed H S Awwad *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-4514-7199
Axel BennerDivision of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
Uta BertschDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Britta BesemerDepartment of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.
Mathias HänelDepartment of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
Roland FenkDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
Markus MunderDepartment of Internal Medicine III, University Hospital Mainz, Mainz, Germany.
Jan DürigDepartment for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
Igor W BlauMedical Clinic, Charité University Medicine Berlin, Berlin, Germany.
Stefanie HuhnDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Dirk HoseDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Anna JauchInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Christoph MannDepartment of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany.
Niels WeinholdDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-5464-3234
Christof ScheidDepartment of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Roland SchroersDepartment of Hematology, Oncology, Ruhr-University Bochum, Bochum, Germany.ORCID 0000-0003-2744-5491
Ivana von MetzlerDepartment of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt a.M., Germany.
Aneta SchieferdeckerDepartment of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jörg ThomallaHematology/Oncology Center, Koblenz, Germany.
Peter ReimerEvang. Kliniken Essen-Mitte, Evang. Krankenhaus Essen-Werden, Essen, Germany.
Rolf MahlbergInternal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany.
Ullrich GraevenDepartment of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.ORCID 0000-0001-6082-7710
Stephan KremersHematology/Oncology Center, Lebach, Germany.
Uwe M MartensHematology, Oncology, Palliative Care, SLK Clinics Heilbronn, Heilbronn, Germany.
Christian KunzHematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany.
Manfred HenselMannheimer Onkologie Praxis, Mannheim, Germany.
Andrea Seidel-GlätzerCoordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany.
Katja C WeiselDepartment of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-9422-6614
Hans J SalwenderAsklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany.ORCID 0000-0001-7803-0814
Carsten Müller-TidowDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-7166-5232
Marc S RaabDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-4181-6922
Hartmut Goldschmidt *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Elias K Mai *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-6226-1252
Michael Hundemer *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. michael.hundemer@med.uni-heidelberg.de.ORCID 0000-0002-5596-2405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD28 AntigensMultiple MyelomaT-Lymphocytes, RegulatoryAntineoplastic Combined Chemotherapy ProtocolsCD8-Positive T-LymphocytesHumansInduction ChemotherapyMalePrognosisProgression-Free SurvivalSurvival RateCD28 Antigens

Identifiers

PMID38830959
PMCPMC11216978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.